Citius Oncology at ASH 2026
Dec 12–15, 2026 New Orleans, LA ~30k attendees Website
Citius Oncology at ASH 2026 in New Orleans: Booth 3255.
| Organization | ASH 2026 Attendance |
|---|---|
Citius Oncology Cranford, NJ | |
Oncology company, majority owned by Citius Pharmaceuticals, marketing LYMPHIR (denileukin diftitox), an FDA-approved immunotherapy for relapsed cutaneous T-cell lymphoma. | Booth Exhibiting at Booth 3255 Sat, Dec 1211:00am–5:00pmSun, Dec 1310:00am–5:00pmMon, Dec 1410:00am–2:00pm |
Find decision makers at Citius Oncology
Tell us what you sell and we’ll find the people at Citius Oncology most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the American Society of Hematology (ASH). Submit a correction